PHARMACEUTICAL ADMINISTRATION FORMS COMPRISING 5-CHLORO-N-({(5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)PHENYL]-1,3-OXAZOLIDIN-5-YL}METHYL)-2-THIOPHENECARBOXAMIDE

• 收藏
• 分享

专利权人:

BAYER PHARMA AKTIENGESELLSCHAFT

发明人:

BENKE, KLAUS,NEUMANN, HEIKE,MÜCK, WOLFGANG

申请号：

TN2014000541

公开号：

TN2014000541A1

申请日:

2014.12.30

申请国别(地区):

TN

年份:

2016

代理人:

摘要：

the present invention relates to solid, orally administrable pharmaceutical administration forms comprising 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide (rivaroxaban, active ingredient (I)), characterized in that a portion of the active ingredient (I) is released in a rapid manner and a portion in a controlled (modified, retarded, delayed) manner, and to processes for production thereof, use thereof as medicaments, and use thereof for prophylaxis, secondary prophylaxis or treatment of disorders.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/